These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32281894)

  • 1. Pharmacotherapeutic management of acute alcohol withdrawal syndrome in critically Ill patients.
    Glahn A; Proskynitopoulos PJ; Bleich S; Hillemacher T
    Expert Opin Pharmacother; 2020 Jun; 21(9):1083-1092. PubMed ID: 32281894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Acute Alcohol Withdrawal Syndrome in Critically Ill Patients.
    Dixit D; Endicott J; Burry L; Ramos L; Yeung SY; Devabhakthuni S; Chan C; Tobia A; Bulloch MN
    Pharmacotherapy; 2016 Jul; 36(7):797-822. PubMed ID: 27196747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of alcohol withdrawal syndrome].
    Sivolap YP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(6):139-144. PubMed ID: 34283544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition, Assessment, and Pharmacotherapeutic Treatment of Alcohol Withdrawal Syndrome in the Intensive Care Unit.
    Foertsch MJ; Winter JB; Rhoades AG; Martin LT; Droege CA; Ernst NE
    Crit Care Nurs Q; 2019; 42(1):12-29. PubMed ID: 30507660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol withdrawal syndromes in the intensive care unit.
    Sarff M; Gold JA
    Crit Care Med; 2010 Sep; 38(9 Suppl):S494-501. PubMed ID: 20724883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Severe Alcohol Withdrawal.
    Schmidt KJ; Doshi MR; Holzhausen JM; Natavio A; Cadiz M; Winegardner JE
    Ann Pharmacother; 2016 May; 50(5):389-401. PubMed ID: 26861990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzodiazepine treatment for alcohol-dependent patients.
    Lejoyeux M; Solomon J; Adès J
    Alcohol Alcohol; 1998; 33(6):563-75. PubMed ID: 9872344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Phenobarbital an Effective Treatment for Alcohol Withdrawal Syndrome?
    Long B; Keim SM; Gottlieb M; Rathlev N
    J Emerg Med; 2024 Nov; 67(5):e494-e503. PubMed ID: 39227241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapies for alcohol abuse. Withdrawal and treatment.
    Saitz R; O'Malley SS
    Med Clin North Am; 1997 Jul; 81(4):881-907. PubMed ID: 9222259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Alcohol Withdrawal Syndrome with and without Dexmedetomidine.
    Beg M; Fisher S; Siu D; Rajan S; Troxell L; Liu VX
    Perm J; 2016; 20(2):49-53. PubMed ID: 27168398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptom-Triggered Therapy for Alcohol Withdrawal Syndrome: a Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Holleck JL; Merchant N; Gunderson CG
    J Gen Intern Med; 2019 Jun; 34(6):1018-1024. PubMed ID: 30937668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of pharmacological approaches in the treatment of alcohol withdrawal syndrome (AWS): a literature review.
    Cooper E; Vernon J
    J Psychiatr Ment Health Nurs; 2013 Sep; 20(7):601-12. PubMed ID: 22989012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological Treatment of Alcohol Withdrawal].
    Teixeira J
    Acta Med Port; 2022 Apr; 35(4):286-293. PubMed ID: 34251331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol, nicotine, and iatrogenic withdrawals in the ICU.
    Awissi DK; Lebrun G; Fagnan M; Skrobik Y;
    Crit Care Med; 2013 Sep; 41(9 Suppl 1):S57-68. PubMed ID: 23989096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?
    Albertson TE; Chenoweth J; Ford J; Owen K; Sutter ME
    J Med Toxicol; 2014 Dec; 10(4):369-81. PubMed ID: 25238670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy of alcohol-withdrawal syndrome in hospitalised patients. Clinical and methodological aspects.
    Busch H; Frings A
    Pharmacopsychiatry; 1988 Sep; 21(5):232-7. PubMed ID: 3067245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency, risk factors and symptomatology of iatrogenic withdrawal from opioids and benzodiazepines in critically Ill neonates, children and adults: A systematic review of clinical studies.
    Duceppe MA; Perreault MM; Frenette AJ; Burry LD; Rico P; Lavoie A; Gélinas C; Mehta S; Dagenais M; Williamson DR
    J Clin Pharm Ther; 2019 Apr; 44(2):148-156. PubMed ID: 30569508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fixed-dose gabapentin augmentation in the treatment of alcohol withdrawal syndrome: a retrospective, open-label study.
    Andaluz A; DeMoss D; Claassen C; Blair S; Hsu J; Bakre S; Khan M; Atem F; Rush AJ
    Am J Drug Alcohol Abuse; 2020; 46(1):49-57. PubMed ID: 31490712
    [No Abstract]   [Full Text] [Related]  

  • 19. A Symptom-Triggered Benzodiazepine Protocol Utilizing SAS and CIWA-Ar Scoring for the Treatment of Alcohol Withdrawal Syndrome in the Critically Ill.
    Sen S; Grgurich P; Tulolo A; Smith-Freedman A; Lei Y; Gray A; Dargin J
    Ann Pharmacother; 2017 Feb; 51(2):101-110. PubMed ID: 27733668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptoms-triggered approach versus fixed-scheduled approach of benzodiazepines for management of alcohol withdrawal syndrome: Non-randomized controlled trial.
    Al-Maqbali JS; Al Alawi AM; Al-Mamari Q; Al-Huraizi A; Al-Maqrashi N
    Alcohol; 2023 Feb; 106():10-14. PubMed ID: 36240945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.